Skip to main content

By Safir Anand

Post a stakeholders meeting held with the new Controller General (CGPDTM) where the legal community had raised concerns on the backlog at the Trade Marks Office (TMO) as also through strong directions given by the Hon’ble High Court of Delhi in petitions filed by Dr. Reddy’s and others, the CGPDTM has been directed to submit a plan for clearance of backlog in opposition matters and for speedy disposal of such matters.

The CGPDTM filed an affidavit declaring details of the pendency post which the TMO has now appointed around 30 Hearing Officers on a contract basis. The sole purpose of the newly appointed Hearing Officers is to clear the longstanding backlog of opposition matters at the TMO. The appointment of more Officers is currently in the works and is expected to be completed soon.

These Officers are strictly instructed by CGPDTM to hear the matters on merits without giving adjournments and to pass orders instantly to clear the pendency of oppositions.

The possibility of initiating a Mediation and Settlement drive on the basis of a further report to be submitted before the Delhi High Court (within the next 8 weeks) is also being considered.

Basis this plan, the CGPDTM is planning to address around 2,00,000 applications by 2025 that have become pending.

The next hearing in the matter has been fixed for August 03, 2022.

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
•
Oct 23, 2026

Imagine a researcher using artificial intelligence to identify a new material, a pharmaceutical team using machine learning to discover a promising compound,

Can AI-Assisted Inventions Be Patented in India?
News & Updates, Thought Leadership
•
Oct 20, 2026

Every time someone publishes an article, uploads a photograph, releases a song or shares research online, they contribute to an expanding body of human

Who Owns Internet’s Knowledge? Copyright, AI Training and Indian Law
News & Updates, Thought Leadership
•
Oct 17, 2026

An active pharmaceutical ingredient (API) is the substance responsible for a medicine’s therapeutic effect. Developing one can involve years of chemical

API Process Patents in India: Key Patent Infringement Disputes and Court Decisions
Thought Leadership
•
Oct 15, 2026

First published on Enterprise IT World. Authored by Subroto Kumar Panda Imagine you gave a supersmart robot a credit card and told it to “buy the best

Taming the AI Beast: How Big Companies Build Safe AI Agents